\
&
Contact us
\
&
Contact us
This was 10 months ago
LocationWebinar
ProgrammesMrs. Ester Hortet Tarroja, legal advisor of the Common Legal Support Centre of DG Research and Innovation of the European Commission, will shed a light on the Means of redress in Horizon Europe.
There will be enough time for your questions towards the speaker and/or the audience.
There is no need to register, simply join the webinar by clicking on this TEAMS link.
The webinar is organized by BE-ARMA, the Belgian Association of Research Managers and Administrators in European funded projects. If you want to be part of this community and get access to peer-to-peer interaction, join the BE-ARMA MS Teams.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
